These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7810126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prevalence of substance abuse among pregnant women in Utah.
    Buchi KF, Varner MW, Chase RA.
    Obstet Gynecol; 1993 Feb; 81(2):239-42. PubMed ID: 8423958
    [Abstract] [Full Text] [Related]

  • 3. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ, Carzoli RP, Sanchez-Ramos L, Murphy S, Khan N, Chiu T.
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Substance abuse during pregnancy in a rural population.
    Sloan LB, Gay JW, Snyder SW, Bales WR.
    Obstet Gynecol; 1992 Feb; 79(2):245-8. PubMed ID: 1731293
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Universal screening for substance abuse at the time of parturition.
    Azadi A, Dildy GA.
    Am J Obstet Gynecol; 2008 May; 198(5):e30-2. PubMed ID: 18279831
    [Abstract] [Full Text] [Related]

  • 10. Perinatal screening for drugs of abuse: reassessment of current practice in a high-risk area.
    Schulman M, Morel M, Karmen A, Chazotte C.
    Am J Perinatol; 1993 Sep; 10(5):374-7. PubMed ID: 8240597
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard.
    Goler NC, Armstrong MA, Taillac CJ, Osejo VM.
    J Perinatol; 2008 Sep; 28(9):597-603. PubMed ID: 18580882
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Trends in HIV-1 and HIV-2 prevalence and risk factors in pregnant women in Harare, Zimbabwe.
    Mbizvo MT, Mashu A, Chipato T, Makura E, Bopoto R, Fottrell PF.
    Cent Afr J Med; 1996 Jan; 42(1):14-21. PubMed ID: 8868380
    [Abstract] [Full Text] [Related]

  • 17. A comparison of common practices for identifying substance use during pregnancy in obstetric clinics.
    Klawans MR, Northrup TF, Villarreal YR, Berens PD, Blackwell S, Bunag T, Stotts AL.
    Birth; 2019 Dec; 46(4):663-669. PubMed ID: 30916432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders.
    Burns L, Mattick RP, Wallace C.
    Nicotine Tob Res; 2008 Jun; 10(6):969-74. PubMed ID: 18584460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.